MuCoS: Efficient Drug-Target Prediction through Multi-Context-Aware Sampling

📅 2025-02-25
📈 Citations: 0
Influential: 0
📄 PDF

career value

160K/year
🤖 AI Summary
Traditional knowledge graph embedding methods for drug–target prediction suffer from poor generalization to unseen relations, overreliance on negative sampling, and inadequate modeling of sparse, dynamic biomedical relationships. To address these limitations, this paper proposes a multi-context-aware end-to-end framework. It introduces a novel density-adaptive neighborhood sampling mechanism that eliminates negative triple sampling entirely. Built upon ComplEx and TransE backbones, the framework incorporates density-aware aggregation to capture local topological patterns and integrates BERT to enable contextualized entity representations. Evaluated on the KEGG50k dataset, our method achieves up to a 13% improvement in Mean Reciprocal Rank (MRR) for general relations and a 6% gain for drug–target relations; Hits@10 improves by up to 18%. Crucially, it significantly enhances zero-shot prediction capability for both unseen entities and unseen relations.

Technology Category

Application Category

📝 Abstract
Drug-target interactions are critical for understanding biological processes and advancing drug discovery. However, traditional methods such as ComplEx-SE, TransE, and DistMult struggle with unseen relationships and negative triplets, which limits their effectiveness in drug-target prediction. To address these challenges, we propose Multi-Context-Aware Sampling (MuCoS), an efficient and positively accurate method for drug-target prediction. MuCoS reduces computational complexity by prioritizing neighbors of higher density to capture informative structural patterns. These optimized neighborhood representations are integrated with BERT, enabling contextualized embeddings for accurate prediction of missing relationships or tail entities. MuCoS avoids the need for negative triplet sampling, reducing computation while improving performance over unseen entities and relations. Experiments on the KEGG50k biomedical dataset show that MuCoS improved over existing models by 13% on MRR, 7% on Hits@1, 4% on Hits@3, and 18% on Hits@10 for the general relationship, and by 6% on MRR, 1% on Hits@1, 3% on Hits@3, and 12% on Hits@10 for prediction of drug-target relationship.
Problem

Research questions and friction points this paper is trying to address.

Improves drug-target interaction prediction
Reduces computational complexity and negative sampling
Enhances accuracy with contextualized embeddings
Innovation

Methods, ideas, or system contributions that make the work stand out.

Multi-Context-Aware Sampling
BERT for contextualized embeddings
Eliminates negative triplet sampling